Real-World Evidence Solutions Market Report by Component (Clinical Settings Data, Claims Data, Patient-Powered Data, Pharmacy Data, and Others), Therapeutic Area (Oncology, Immunology, Neurology, Cardiovascular Disease, and Others), End User (Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers, and Others), and Region 2024-2032

Real-World Evidence Solutions Market Report by Component (Clinical Settings Data, Claims Data, Patient-Powered Data, Pharmacy Data, and Others), Therapeutic Area (Oncology, Immunology, Neurology, Cardiovascular Disease, and Others), End User (Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A6149
Buy Now

1    Preface
2    Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction
    4.1    Overview
    4.2    Key Industry Trends
5    Global Real-World Evidence Solutions Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Component
    6.1    Clinical Settings Data
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Claims Data
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Patient-Powered Data
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Pharmacy Data
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7    Market Breakup by Therapeutic Area
    7.1    Oncology
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Immunology
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Neurology
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Cardiovascular Disease
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by End User
    8.1    Pharmaceutical and Medical Device Companies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Healthcare Payers
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Healthcare Providers
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis
    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Aetion Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
        14.3.2    Clinigen Limited
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
        14.3.3    Flatiron Health Inc. (Roche Holding AG)
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    ICON plc
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    International Business Machines Corporation
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
        14.3.6    IQVIA
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Optum Inc. (UnitedHealth Group Incorporated)
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Oracle Corporation
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Parexel International Corporation
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
        14.3.10    PPD Inc. (Thermo Fisher Scientific Inc.)
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
        14.3.11    Sas Institute Inc.
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 SWOT Analysis
        14.3.12    Syneos Health
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio
           14.3.12.3 Financials
           14.3.12.4 SWOT Analysis

List of Figures

Figure 1: Global: Real-World Evidence Solutions Market: Major Drivers and Challenges
Figure 2: Global: Real-World Evidence Solutions Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Real-World Evidence Solutions Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Real-World Evidence Solutions Market: Breakup by Component (in %), 2023
Figure 5: Global: Real-World Evidence Solutions Market: Breakup by Therapeutic Area (in %), 2023
Figure 6: Global: Real-World Evidence Solutions Market: Breakup by End User (in %), 2023
Figure 7: Global: Real-World Evidence Solutions Market: Breakup by Region (in %), 2023
Figure 8: Global: Real-World Evidence Solutions (Clinical Settings Data) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Real-World Evidence Solutions (Clinical Settings Data) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Real-World Evidence Solutions (Claims Data) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Real-World Evidence Solutions (Claims Data) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Real-World Evidence Solutions (Patient-Powered Data) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Real-World Evidence Solutions (Patient-Powered Data) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Real-World Evidence Solutions (Pharmacy Data) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Real-World Evidence Solutions (Pharmacy Data) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Real-World Evidence Solutions (Other Components) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Real-World Evidence Solutions (Other Components) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Real-World Evidence Solutions (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Real-World Evidence Solutions (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Real-World Evidence Solutions (Immunology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Real-World Evidence Solutions (Immunology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Real-World Evidence Solutions (Neurology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Real-World Evidence Solutions (Neurology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Real-World Evidence Solutions (Cardiovascular Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Real-World Evidence Solutions (Cardiovascular Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Real-World Evidence Solutions (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Real-World Evidence Solutions (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Real-World Evidence Solutions (Pharmaceutical and Medical Device Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Real-World Evidence Solutions (Pharmaceutical and Medical Device Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Real-World Evidence Solutions (Healthcare Payers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Real-World Evidence Solutions (Healthcare Payers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Real-World Evidence Solutions (Healthcare Providers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Real-World Evidence Solutions (Healthcare Providers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Real-World Evidence Solutions (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Real-World Evidence Solutions (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: North America: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: North America: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: United States: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: United States: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Canada: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Canada: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Asia-Pacific: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Asia-Pacific: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: China: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: China: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Japan: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Japan: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: India: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: India: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: South Korea: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: South Korea: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Australia: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Australia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Indonesia: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Indonesia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Others: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Europe: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Europe: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Germany: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Germany: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: France: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: France: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: United Kingdom: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: United Kingdom: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Italy: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Italy: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Spain: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Spain: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Russia: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Russia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Others: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Latin America: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Latin America: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Brazil: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Brazil: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Mexico: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Mexico: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Others: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Middle East and Africa: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Middle East and Africa: Real-World Evidence Solutions Market: Breakup by Country (in %), 2023
Figure 84: Middle East and Africa: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Global: Real-World Evidence Solutions Industry: SWOT Analysis
Figure 86: Global: Real-World Evidence Solutions Industry: Value Chain Analysis
Figure 87: Global: Real-World Evidence Solutions Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Real-World Evidence Solutions Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Real-World Evidence Solutions Market Forecast: Breakup by Component (in Million US$), 2024-2032
Table 3: Global: Real-World Evidence Solutions Market Forecast: Breakup by Therapeutic Area (in Million US$), 2024-2032
Table 4: Global: Real-World Evidence Solutions Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Real-World Evidence Solutions Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Real-World Evidence Solutions Market: Competitive Structure
Table 7: Global: Real-World Evidence Solutions Market: Key Players

Real-World Evidence Solutions Market Report by Component (Clinical Settings Data, Claims Data, Patient-Powered Data, Pharmacy Data, and Others), Therapeutic Area (Oncology, Immunology, Neurology, Cardiovascular Disease, and Others), End User (Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers, and Others), and Region 2024-2032
Purchase options




Inquire Before BuyingInquire Before Buying
Speak to an AnalystSpeak to an Analyst     
Request BrochureRequest Brochure         
Request CustomizationRequest Customization
Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More

Services

Industries

Industries

Quick Links

Contact us

United States

134 N 4th St. Brooklyn, NY 11249, USA

+1-631-791-1145

India

Level II & III, B-70, Sector 2, Noida, Uttar Pradesh 201301, India

+91-120-433-0800

United Kingdom

30 Churchill Place London E14 5EU, UK

+44-753-713-2163

Competitive Intelligence and Benchmarking Consumer Surveys and Feedback Reports Market Entry and Opportunity Assessment Pricing and Cost Research Procurement Research Report Store
Aerospace and Defense Agriculture Automotive BFSI Chemicals and Materials Construction and Manufacturing Electronics and Semiconductors Energy and Mining Food and Beverages Healthcare Packaging Retail Technology and Media Transportation and Logistics
Media Room Blogs Press Releases Our Customers Become a Publisher FAQ's

Contact us

United States

134 N 4th St. Brooklyn, NY 11249, USA

+1-631-791-1145

India

Level II & III, B-70 , Sector 2, Noida, Uttar Pradesh 201301, India

+91-120-433-0800

United Kingdom

30 Churchill Place London E14 5EU, UK

+44-753-713-2163

© Copyright IMARC Services Private Limited 2024. All rights reserved. Terms & Conditions | Privacy Policy | SiteMap